Protective effect of hesperidin on experimental liver fibrosis in rats

Wu Furong,Li Jun,Ren Danyang

DOI: https://doi.org/10.3969/j.issn.1000-1492.2011.04.015

2011-01-01

Abstract:Objective To investigate the anti-liver fibrosis effect of hesperidin(HDN) in rats.Methods Rat liver fibrosis was induced by 50% CCl4 twice a week for 12 weeks.From the 7th week,all the therapeutic groups were treated with the HDN(50,100,200 mg/kg)and colchicine(0.1 mg/kg)respectively for 6 weeks.The levels of ALT,AST,HA,LN,PⅢNP,CIV,TGF-β1,MDA and SOD were measured.HE staining was used to evaluate the degree of hepatic fibrosis.The mRNA expression of TGF-β1 in liver tissue was detected by RT-PCR.Results HDN(50,100,200 mg/kg)not only reduced the levels of ALT,AST,HA,LN,PⅢNP,CIV,MDA,TGF-β1 significantly and the degree of hepatic fibrosis,but also increased SOD activity.Moreover,HDN decreased the mRNA expression of TGF-β1 in liver tissues obviously.Conclusion HDN has anti-liver fibrosis effect,which may be associated with its free-radical scavenging ability and TGF-β1 regulation.